Difficulty: Medium
Average Score: 94%
Practice
Choose the correct statement about the role of opioid antimotility drugs in the management of diarrhoeas
Correct answer
B
Rationale
In the management of diarrhoea, the correct statement is option B) "They should be used only as a short-term measure after ensuring that enteroinvasive organisms are not involved." This statement is accurate because opioid antimotility drugs should be cautiously used for short-term relief in non-infectious diarrhoea to avoid suppressing the body's natural defense mechanism of flushing out harmful pathogens. Prolonged use can lead to serious complications like toxic megacolon.
Option A is incorrect as opioid antimotility drugs should not be used indiscriminately for all types of diarrhoea. Option C is incorrect as these drugs are not typically used as adjuvants to antimicrobial therapy. Option D is also incorrect as opioids are not the first-line treatment for irritable bowel syndrome diarrhoea due to their potential for dependence and adverse effects.
In an educational context, understanding the appropriate use of opioid antimotility drugs in diarrhoea management is crucial for healthcare professionals to ensure safe and effective treatment. It highlights the importance of differentiating between infectious and non-infectious diarrhoea and using these drugs judiciously to prevent complications and promote patient well-being.
Option A is incorrect as opioid antimotility drugs should not be used indiscriminately for all types of diarrhoea. Option C is incorrect as these drugs are not typically used as adjuvants to antimicrobial therapy. Option D is also incorrect as opioids are not the first-line treatment for irritable bowel syndrome diarrhoea due to their potential for dependence and adverse effects.
In an educational context, understanding the appropriate use of opioid antimotility drugs in diarrhoea management is crucial for healthcare professionals to ensure safe and effective treatment. It highlights the importance of differentiating between infectious and non-infectious diarrhoea and using these drugs judiciously to prevent complications and promote patient well-being.